EUVIMEDEUVIMED entdecken
Crossref

Oseltamivir-Associated Supraventricular Tachycardia in a Neonate

Elif Duygu Kutbe, Huseyin Pur, Erhan Sonmez, Cagdas Vural, Ali Baykan

The Journal of Pediatric Pharmacology and Therapeutics · 15.06.2026

DOI: 10.5863/jppt-25-00098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pediatric Pharmacology and Therapeutics, erschienen am 15.06.2026. Verfasst von Elif Duygu Kutbe und 4 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The most common type of tachyarrhythmia in neonates is supraventricular tachycardia (SVT), which affects 1:250 to 1000 children and usually appears in the first year of life. Although some patients are asymptomatic, others may present with poor feeding, rapid breathing, and irritability. If left untreated, the condition can progress to heart failure and cardiogenic shock. This report describes a 20-day-old male neonate who developed SVT while receiving oseltamivir treatment for influenza and recovered with adenosine treatment. It also highlights the importance of avoiding possible triggers, early diagnosis, and treatment of SVT in neonates.

Zitieren

APA

Kutbe, E. D., Pur, H., Sonmez, E., Vural, C., & Baykan, A. (2026). Oseltamivir-Associated Supraventricular Tachycardia in a Neonate. The Journal of Pediatric Pharmacology and Therapeutics. https://doi.org/10.5863/jppt-25-00098

Vancouver

Kutbe ED, Pur H, Sonmez E, Vural C, Baykan A. Oseltamivir-Associated Supraventricular Tachycardia in a Neonate. The Journal of Pediatric Pharmacology and Therapeutics. 2026. doi:10.5863/jppt-25-00098

BibTeX
@article{Kutbe2026,
  author = {Kutbe, Elif Duygu and Pur, Huseyin and Sonmez, Erhan and Vural, Cagdas and Baykan, Ali},
  title = {Oseltamivir-Associated Supraventricular Tachycardia in a Neonate},
  journal = {The Journal of Pediatric Pharmacology and Therapeutics},
  year = {2026},
  doi = {10.5863/jppt-25-00098}
}
Kostenlos starten →